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Dopaminergic activity within the dorsolateral prefrontal cortex (dlPFC) has been implicated in 
the control of cognitive flexibility. Much of the evidence for a causative relationship between 
cognitive flexibility and dopamine has come from animal studies, whilst human data have 
largely been correlational. 
Objective/Hypothesis:  
The current study examines whether changes in dopamine levels through tyrosine 
administration and suppression of dlPFC activity via cathodal tDCS could be causally related to 
cognitive flexibility as measured by task switching and reversal learning.  
Methods: 
Using a crossover, double-blind, sham controlled, counterbalanced, randomized trial, we 
tested the effects of combining cathodal tDCS with tyrosine, a catecholaminergic precursor, 
with appropriate drug and tDCS placebo controls, on two measures of cognitive flexibility: 
probabilistic reversal learning, and task switching. 
Results: 
While none of the manipulations had an effect on task switching, there was a significant main 
effect of cathodal tDCS and tyrosine on reversal learning.  Reversal learning performance was 
significantly worsened by cathodal tDCS compared with sham tDCS, whilst tyrosine 
significantly improved performance compared with placebo. However, there was no significant 
tDCS x drugs interaction. Interestingly, and as predicted by our model, the combined 
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administration of tyrosine with cathodal tDCS resulted in performance that was equivalent to 
the control condition (i.e. tDCS sham + placebo).  
Conclusions: 
Our results suggest a causative role for dopamine signalling and dorsolateral prefrontal cortex 
activity in regulating indices of cognitive flexibility in humans.  
 




Cognitive flexibility, often referred to as behavioural flexibility in animal studies [1], is an 
essential subdomain of executive function (EF) that facilitates goal-directed behavioural 
adaptations in response to changing circumstances [2].  The neuronal network subserving 
cognitive flexibility is thought to include frontostriatal circuits, specifically involving  
dorsolateral/medial prefrontal cortex (dlPFC/dmPFC), anterior cingulate cortex (ACC), 
orbitofrontal cortex (OFC), nucleus accumbens (NAC) and the dorsomedial striatum (DMS) [3-
6].  
Much of our understanding of the neuronal underpinnings of cognitive flexibility comes from 
animal studies, which have utilised a combination of lesion, pharmacological and optogenetic 
approaches; traditionally, human studies have largely been correlational in nature.  Recently, 
however, human studies have begun to investigate causality, via the use of non-invasive brain 
stimulation, particularly transcranial direct current stimulation (tDCS).  Anodal tDCS applied to 
the left dlPFC facilitates cognitive control (a subdomain of EF required for cognitive flexibility 
[7, 8] and cathodal dlPFC stimulation has detrimental effects on cognitive control in a 
hemisphere-dependent manner: cathodal tDCS applied to the right dlPFC negatively impacts 
performance, whereas stimulation of the left dlPFC has no behavioural impact [9, 10]. 
Cognitive flexibility has also been tested more directly using set-shifting/task switching tasks, 
but the results of these have not been entirely reproducible.  Anodal tDCS to the dlPFC was 
shown to improve performance in three studies [11-13] and in a fourth study cathodal, but not 
anodal, stimulation improved certain aspects of cognitive flexibility (post-error slowing in the 
WCST) but not others (perseverative or total errors in the WCST) [14]. In two of the four 
studies cited [12, 14], stimulation of left dLPFC was shown to be effective, whereas in the 
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other two [11, 13], the left and right hemisphere of the dlPFC contributed to different aspects 
of task-switching performance. 
It has been hypothesised that endogenous dopaminergic activity may potentially explain these 
somewhat contradictory findings.  The involvement of dopamine in regulating cognitive 
flexibility particularly in animal studies is well-documented [15]. In humans, studies in which 
brain dopamine levels were enhanced by the administration of the dopamine precursor 
tyrosine have shown that increases in dopamine are beneficial to cognitive control [16, 17] and, 
importantly, cognitive flexibility [18].  
In a series of recent studies, the effects of dlPFC tDCS on set-shifting was shown to be 
dependent on the Val(108/158)Met COMT polymorphism, known to affect individuals’ 
dopaminergic activity. Specifically, cathodal tDCS was detrimental to task performance in 
subjects with low dopaminergic activity (i.e. those who were Val/Val homozygous) but had no 
effect in those with normal dopaminergic activity (i.e. with at least one Met allele) [19].  
Anodal tDCS was detrimental to task performance in individuals with high dopaminergic 
activity (Met/Met homozygous), but had no effect on task performance in the Val carriers.   
A parsimonious model for these results was suggested by the authors (Fig 1A).  In this 
framework, it was postulated that cathodal tDCS acts to decrease dopaminergic activity, which 
would have little effect on cognitive performance in the Met allele carriers but would 
significantly impair performance in the Val/Val group as it would reduce the level of neuronal 
activity below that for optimal performance.  Anodal tDCS would act to increase activity, which 
would have little effect on cognitive performance in the Val/Val carriers, but would increase 
the level of neuronal activity beyond the optimal range in the Met carriers [20].  A recent study 
where endogenous dopaminergic activity was increased via tyrosine administration, showed 
tDCS effects on working memory that were in line with this theoretical framework [21].  It is 
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important to note, however, that tDCS cortical excitability effects may not be directly related 
to dopamine.  With particular reference to cathodal tDCS aftereffects (as used in the current 
study), the evidence points at a role of glutamate [22], with administration of NMDA 
antagonists blocking intracortical facilitation [23] and diminished concentration of glutamate 
within the stimulated area [24].  
The current study examined whether increases in endogenous dopaminergic activity via 
tyrosine and the (presumed) suppression of these by cathodal tDCS of the dlPFC could causally 
be related to cognitive flexibility as measured by task switching and reversal learning. In a 
crossover, double-blind, sham-controlled randomized trial, we tested the single and 
combinatory effects of tyrosine administration and cathodal tDCS of the dlPFC. Based on the 
theoretical framework outlined above, we predicted that tyrosine with sham tDCS would be 
most beneficial to cognitive flexibility. The addition of cathodal tDCS to tyrosine would remove 
the behavioural improvements provided by tyrosine alone, and performance during placebo 
plus sham tDCS would be similar to that in the tyrosine plus cathodal tDCS condition. Finally, 
we predicted that performance would be at its worst during placebo and cathodal tDCS 
condition.  
Materials and methods 
Participants 
Twenty-four university students took part in the study (M= 20.8, SD= 2.2, 15 females and 9 
males).  The study was approved by the ethics committee of Sheffield Hallam University and 
complied with the Declaration of Helsinki. The study is registered in ClinicTrials.gov (identifier: 
NCT03068884). Sample size was determined using G*Power 3.1 to obtain a power level of 80% 
based on repeated measures ANOVA analyses (1 group, 4 measurements) with a large effect 
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size of 0.14 (partial eta squared) and p value at 0.05.  Exclusion criteria included: those 
suffering from cardiac, hepatic, renal and neurological disorders and individuals with a history 
of alcohol or drug addiction (including nicotine), or psychiatric illness. Participants were 
excluded if they were pregnant, were taking medications known to lower seizure threshold, or 
reported having taken tyrosine supplements.  
Experimental design and procedure 
The experimental protocol is summarised in Fig 1B. Briefly, this was a double-blind, crossover, 
sham/placebo-controlled, randomized trial with counterbalancing of conditions. Participants 
were required to attend four experimental sessions each lasting approximately 120 minutes 
for a total financial reward of £50. The four experimental sessions (conditions) consisted of: 
tyrosine plus cathodal tDCS; tyrosine plus tDCS sham; placebo plus cathodal tDCS; and placebo 
plus tDCS sham. A Latin square design was adopted to allocate condition order. To avoid 
potential carryover effects of either tyrosine and/or tDCS, each session was separated by at 
least 72 hours.  
After screening for eligibility, participants were instructed to refrain from eating/drinking 
overnight for a minimum of 8 hours prior to testing. In each experimental session, participants 
first completed the mood questionnaire (VAS) (VAS1). This was followed by cognitive testing 
(T1) with the order of presentation of the WCST and PRL being counterbalanced for each 
participant in each session. The same cognitive tasks were presented across experimental 
sessions, sequentially. After completing mood and cognitive testing, either tyrosine or placebo 
was given. Sixty minutes after tyrosine/placebo intake, a second VAS was completed (VAS2), 
and cathodal or sham tDCS was administered for 20 minutes.  
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The choice of one hour wait prior to tDCS was based on the finding that peak plasma 
concentration for tyrosine occur approximately after this period [25]. Immediately after tDCS, 
a third VAS was given (VAS3), and cognitive testing began (T2). At the end of the second 
cognitive testing, a final VAS was completed (VAS4), and participants were asked to report 
whether they thought that tyrosine/placebo and cathodal tDCS/sham had been administered. 
Participants took an average of 15 minutes to complete the cognitive tasks (see Fig 1B) with 
some individuals taking close to 20 minutes. After effects of cathodal tDCS have been 
demonstrated to last for up to 1 hour both when measured using motor evoked potentials [26-
28] and brain perfusion changes [29].   
Cognitive measures 
Task switching and reversal learning were measured using the Psychology Experiment Building 
Language (PEBL) test battery [30].  Task switching was assessed using an adaptation of the 
Wisconsin Card Sorting Test (WCST) [31, 32].  The dependent measure was the total number of 
errors (regardless of whether these were perseverative or not). To assess reversal learning, we 
used the probabilistic reversal learning (PRL) paradigm developed by Cools et al [4].  Here, 
using trial-and-error feedback, participants need to discover which of two patterns is correct.  
To complete the PRL, participants had to complete four blocks of trials, and 40 reversals. We 
took mean errors per reversal as the dependent measure of interest (this is also equivalent to 
total number of errors if one multiplies mean errors per reversal by 40). In both WCST and PRL, 
participants were given practice trials before testing began and subjects were asked to 
respond as quickly and accurately as possible.  
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Drug administration 
Participants received either 2.0 g of l-Tyrosine (supplied by BulkPowders Ltd.) or 2.0 g of the 
placebo microcrystalline cellulose (Sigma-Aldrich Co. LLC). This dosage has been shown to 
modulate a number of cognitive domains including deep thinking, working memory, cognitive 
control, and cognitive flexibility [16-18, 25, 33-35].  Both Tyrosine and placebo were dissolved 
in 400ml of orange juice as per previously published protocols [16, 25].  
Transcranial direct current stimulation 
A DC Stimulator Plus (neuroConn, Germany) with two 5cm x 7cm rubber electrodes, encased in 
saline soaked sponges was used.  The cathode was positioned over the left dlPFC, centered on 
F3 in the 10-20 electroencephalography (EEG) system, while the anode on the contralateral 
supraorbital ridge (Fp2). Current was delivered at 1.5 mA for 20 minutes plus 30 seconds fade 
in/fade out periods. 1.5 mA was chosen based on previous reports which demonstrate that 
current at 2.0 mA can compromise the blinding robustness of the tDCS procedure [36-38].  For 
sham stimulation, the current was faded in over 30 seconds, ran for 1.5 mA and then switched 
off.  Double-blinding was achieved using the neuroConn study mode software.  
Measurement of alertness and mood 
The potential influence of mood and alertness on cognitive flexibility was measured using a 
computerized adaptation of commonly administered visual analog scales (VAS) run in PEBL. 
Seven dimensions of mood/alertness were, recorded with a total minimum score of 7 (low 
mood/alertness) and a maximum total score of 147 (high mood/alertness).  
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At the end of each experimental session participants were asked to report whether they 
thought that active (i.e. cathodal) or sham tDCS had been delivered, and whether tyrosine or 
placebo (i.e. cellulose) had been administered.  
Statistical analysis 
Statistical analyses were performed using SPSS version 23 (SPSS Inc). The two dependent 
measures for cognitive flexibility were mean errors per reversal for the PRL and total number 
of errors for the WCST. We first used a one-way repeated measure ANOVA with one factor of 
condition ([cathodal tDCS + tyrosine], [sham tDCS + tyrosine], [cathodal tDCS + placebo], [sham 
tDCS + placebo]) to test whether there were performance differences at baseline (i.e. pre-
drug/tDCS). If no significant differences at baseline were noted for both dependent measures, 
we calculated a percentage change at time 2 (post-drug/tDCS) compared with time 1 (pre-
drug/tDCS). We then run 2x2 repeated factorial ANOVAs with one factor, tDCS (2 levels: sham, 
cathodal), and the second factor drugs (2 levels: placebo, tyrosine) to test for main effects 
(tDCS, drugs) and interactions.    
Mood data were analysed using a two-way factorial repeated measures ANOVA, where the 
factor of Time had four levels (VAS 1-4), with Bonferroni post-hoc corrections applied. 
The double blinding efficacy of tyrosine/placebo and cathodal tDCS/sham was analysed using a 
percentage correct measure.  A score of 1 was given if a participant correctly identified 
condition whereas a score of 0 if not. We investigated the combined effects of drug 
(tyrosine/placebo) plus tDCS stimulation (cathodal/sham) on accuracy rates. Here chance level 
was 25% and a Cochran's Q test for dichotomous data was used to investigate significance.  In 
all tests, a p value of < 0.05 was considered significant.  
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Results 
Putative dopamine increases and cathodal tDCS lead to changes in 
probabilistic reversal learning (PRL) 
A one-way repeated measures ANOVA with one factor of Condition demonstrated no 
significant difference in performance at baseline (i.e. pre-drug & tDCS; Time 1) between 
sessions [F (2.00, 46.19) = 2.37, p = 0.104]. We therefore calculated percentage change in 
mean errors per reversal at time 2 compared with time 1. A 2x2 factorial repeated measures 
ANOVA demonstrated a significant main effect of tDCS [F (1, 23) = 5.37, p = 0.030, Ƞp
2=.19], 
with cathodal tDCS of the dlPFC negatively affecting performance compared to sham (Fig 2A). 
We also report a significant main effect of drugs [F (1, 23) =5.98, p= 0.023, Ƞp
2=.20], with 
tyrosine administration positively affect performance compared to placebo (Fig 2B). There was 
no significant tDCS x drug interaction [F (1, 23) =.12, p=0.729, Ƞp
2=.00].  
To check for potential practice/ceiling effects of PRL testing, we compared reversal errors 
during pre-drug/tDCS across the 4 sessions. We found that amount of practice did not produce 
a significant change in reversal errors [F (3, 69) =1.02, p=.386]. 
No significant effect on Wisconsin Card Sorting Test (WCST) 
The primary dependent measure of interest in the WCST was total number of errors.  As with 
the PRL, there was no difference in errors at time 1 across the sessions [F (2.21, 51.00) =1.67, 
p=0.181]. We therefore calculated percentage change in total errors at Time 2 compared with 
time 1.  A 2x2 factorial repeated measures ANOVA revealed no main effect of tDCS [F (1, 23) 
=0.01, p= 0.900, Ƞp
2=.00] (Fig 3A), nor a main effect of drugs [F (1, 23) =0.90, p= 0.352, Ƞp
2=.03] 
(Fig 3B) nor a tDCS x drugs interaction [F (1, 23) =0.47, p= 0.498, Ƞp
2=.02].  
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Non-condition-dependent increase in mood and alertness during session 
Results from the VAS are summarised in the Supplementary Material Table S1. There was no 
significant main effect of Condition on mood [F (1.79, 41.20) = 1.05, p= .374]. However, there 
was a significant main effect of Time [F (2.23, 51.42) = 7.19, p=.001, η2p = .23]. Bonferroni-
adjusted post hoc t-tests revealed that mood significantly improved from VAS 1 (baseline) (M= 
99.7, SD=20.1) to VAS 3 (post-drug/tDCS) (M=108, SD=17.8) (p=.006) and from VAS 2 (post-
drug) (M=103.5, SD=17.5) to VAS 3 (post-drug/tDCS) (p=.002), but not between VAS 1 and VAS 
2 (p=.508), VAS 1 and VAS 4 (M=105.5, SD=19.6) (p= .085), VAS 2 and VAS 4 (p= 1.00) and VAS 
3 and VAS 4 (p= .652).  There was no significant interaction between Condition and Time [F 
(4.46, 102.78) = .97, p=.887], indicating that improvement in mood occurred independent of 
Condition.  
Effective participant-blinding across sessions 
We analysed the probability of a subject correctly identifying which condition they had 
received in any given session.   Mean accuracy rate across conditions was at chance at 25%. 
Cochran's Q test determined that there was no statistically significant difference in the 
proportion of participants accurately guessing their condition, X2 (3) =5.455, p=0.141, 
confirming the efficacy of the blinding across sessions.   
 
Discussion 
The aim of this study was to investigate the role of catecholaminergic modulation in cognitive 
flexibility, and whether this role could be modulated by tDCS inhibition of the dlPFC. We found 
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an effect on one sub-domain of cognitive flexibility, namely, reversal learning but not task-
switching. Our finding that cathodal tDCS impacts reversal learning but not task-switching 
therefore suggests that these two subdomains of cognitive flexibility may be controlled by a 
differential neuronal network. Although the dlPFC seems to be involved in both reversal 
learning and WCST [4, 39], there appears to be a differentiation with respect to the subcortical 
regions that contribute to the execution of these tasks [3, 40].  It may be, therefore, that dlPFC 
tDCS differentially affects these anatomically distant subcortical regions [41]  [29, 42]. 
 As predicted by our model, performance on the [cathodal tDCS+ placebo] condition was worst, 
with [sham tDCS + placebo] and [cathodal tDCS + tyrosine] second, and [sham tDCS + tyrosine] 
best. The absence of a statistically significant interaction between tDCS (sham, cathodal) and 
drugs (placebo, tyrosine) is not unexpected and predicted from our model (Fig 1A). In that, the 
only comparison hypothesised to significantly differ was the [cathodal tDCS + placebo] 
condition with the [sham tDCS + tyrosine]. Nevertheless, there remain a number of open 
questions as to the physiological mechanisms that resulted in these effects. In the following 
section, we will attempt to provide some potential explanations.  
The detrimental effects of cathodal tDCS applied to dlPFC on specific aspects of cognitive 
flexibility (i.e. reversal learning) but not others (i.e. task switching) are in line with some 
previous findings [9, 10], but not entirely with others [14]. Methodological differences 
between studies including disparate measures of cognitive flexibility being used, on-line versus 
offline stimulation, left or right hemisphere targeting, size of the stimulating electrode, 
position of the reference electrode, the employment of between subjects versus crossover 
designs, duration of stimulation, means that comparisons should be made with caution. 
Several reviews have evaluated the influence of these methodological variables on the 
reproducibility of tDCS findings [43-45]. We cannot, for example, categorically exclude the 
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influence of the reference/return electrode on cognitive flexibility performance, as the 
reference electrode can have differential physiological effects depending on whether this is 
placed over another cranial area or in extracranial regions [46, 47]. This is an issue that relates 
more generally, to tDCS spatial resolution as modelling studies demonstrate that the 
target/active electrode elicits peak electrical fields that are 2 to 4 cm away from the electrode 
[48-50].     
The primary goal of this research was to understand the modulation of dopaminergic agents 
on tDCS effects whilst acknowledging the contribution that other factors play to affecting tDCS 
results.  
The observation that (cathodal tDCS + placebo) and (sham tDCS + tyrosine) were at opposite 
ends of reversal learning performance may relate to different mechanisms. First, the negative 
effects on performance were specific to the inhibition of activity of dlPFC neurons. This 
inhibition may have a dopaminergic component as highlighted by previous reports on 
dopamine polymorphisms and cathodal dlPFC [19, 20]. In line with this mechanistic hypothesis, 
participants with low baseline dopamine levels are negatively affected by cathodal tDCS. 
Conversely, in participants with high COMT activity, anodal tDCS negatively impacts cognitive 
flexibility. This supports a long-standing view of a nonlinear inverted U-relationship between 
dopamine concentrations and performance. Nevertheless, the possibility that cathodal tDCS 
may affect other neurotransmitters, chiefly glutamate but also GABA, cannot be excluded [24, 
51].  
Second, the positive effects on performance can be attributed to overall increases in dopamine 
synthesis across the brain as opposed to being specific to the dlPFC. Whilst both tyrosine 
(alone) and anodal dlPFC (alone) have been reported to improve cognitive flexibility [11-13, 
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18], it is plausible that these improvements are the result of different neurobiological 
mechanisms. 
A particular goal of this investigation was to test the hypothesis that the combined 
administration of tyrosine with cathodal dlPFC could in effect, render performance 
indiscernible from that of the control condition [tDCS sham + placebo]. The data support our 
original hypothesis. This, at least behaviourally, points at tyrosine (and indirectly dopamine) 
modulating tDCS effects on reversal learning, as shown by a recent report looking at working 
memory [35].   
Physiologically, the effect of tyrosine on cortical excitability combined with cathodal tDCS 
would need to be confirmed. Previous studies have shown that the dopamine precursor L-
DOPA eliminated the expected decrease in cortical excitability observed after cathodal tDCS at 
low and high doses [52], but this effect was dose-dependent: a medium dose had no effect [52, 
53].   
Although both tyrosine and L-DOPA are dopamine precursors, the conversion of the tyrosine 
into dopamine is restricted, both by competition from other endogenous amino acids and by 
the rate-limiting tyrosine-hydroxylase enzyme, meaning that tyrosine administration does not 
lead to greatly elevated concentrations of dopamine [54]. Conversion of L-DOPA into 
dopamine, on the other hand, is not influenced by the above factors. It is plausible, therefore, 
that effects on dopamine levels of the tyrosine in our study was equivalent to administering a 
low dose of L-DOPA.  
 However, it is worth emphasizing that there are no published data comparing the 
bioequivalence of tyrosine dosage to L-dopa, thus future studies would need to establish this.  
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Conclusion 
We provide preliminary behavioural evidence that dopaminergic administration modulates 
tDCS effects on cognitive flexibility. Our findings contribute to an expanding literature which 
aims to uncover factors that underlie the known inter-subject variability of this technique. 
Future investigations that manipulate tyrosine availability such as the acute 
tyrosine/phenylalanine depletion procedure [55, 56] combined with tDCS would aid our 
understanding of the relationship between the inverted U-relationship between dopamine 
concentrations and performance and tDCS polarity.    
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